Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelogenous, Chronic, BCR-ABL Positive × darolutamide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 39 Salivary Gland Neoplasms 3 Prostatic Neoplasms, Castration-Resistant 3 Neoplasms 3 Urogenital Neoplasms 2 Prostatic Diseases 2 Non-metastatic Castration-resistant Prostate Cancer 2 Neoplasm Metastasis 2 Metastatic Castration-resistant Prostate Cancer 2 Male Urogenital Diseases 2 Bulbo-Spinal Atrophy, X-Linked 2 Biochemically Recurrent Prostate Cancer 2 Adenocarcinoma 2 Urogenital Diseases 1 Triple Negative Breast Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Prostate Adenocarcinoma 1 Neoplasms by Site 1 Metastatic Castration-resistant Prostate Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 High-Risk Localized Prostate Cancer 1 Granulosa cell tumor of the ovary 1 Genital Diseases, Male 1 Fatigue 1 Depression 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 28 fludarabine 20 Whole-Body Irradiation 19 fludarabine phosphate 18 asciminib 18 Mycophenolic Acid 17 nilotinib 14 Tacrolimus 14 Imatinib Mesylate 12 Melphalan 11 Dasatinib 9 ponatinib 8 bosutinib 8 Thiotepa 8 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mesna 6 Granulocyte Colony-Stimulating Factor 6 Filgrastim 5 venetoclax 4 olverembatinib 4 blinatumomab 4 Stem Cell Transplantation 4 Sirolimus 4 ruxolitinib 3 Rituximab 3 Hematopoietic Stem Cell Transplantation 3 Cyclosporine 3 Bone Marrow Transplantation 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡